Skip to main content

VICC Seminar Series

The VICC Seminar Series is held on Thursdays throughout the academic year.  

Upcoming VICC Seminars 

View more events on

Watch past lectures

**Requires VUnetID/password and a browser that supports Silverlight technology (e.g., Internet Explorer, Mozilla Firefox for Windows).** 

Fall 2018 - Spring 2019

Chemokines in Cancer Immunotherapy and Inflammation (Apr. 11, 2019) - Video not available
Andrew  D Luster , PhD, MD
Chief, Division of Rheumatology, Allergy and Immunology; Director, Center for Immunology and Inflammatory Diseases; E. Alexandria and Michael B. Altman Chair in Immunology: Persis, Cyrus and Marlow B. Harrison Professor of Medicine
Harvard Medical School

Alternative RNA Splicing as a Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities (Mar. 21, 2019)
Steven Patierno, PhD
Professor of Medicine, Professor of Pharmacology and Cancer Biology, Professor in Community and Family Medicine, Member of the Duke Cancer Institute

From GWAS to Gene: Mechanisms and Predictions for Chemotherapeutic Compounds (Mar. 14, 2019)
Erik Andersen, PhD
Assistant Professor of Molecular Biosciences
Northwestern University

How Precise is Precision Medicine? (Feb. 28, 2019) - Video not available
Richard Marais, PhD
Director, Cancer Research UK Manchester Institute
Professor of Medical Oncology, University of Manchester

The Exosomes in Immunosuppression and Tumor Progression (Feb. 21, 2019) - Video not available
Wei Guo, PhD
Professor of Biology
University of Pennsylvania

Cancer and Aging: Implications for Cancer Survivors (Feb. 14, 2019)
Patricia Ganz, MD
Professor of Health Policy and Management, Fielding School of Public Health Professor of Medicine, David Geffen School of Medicine at UCLA; Director of the Center for Cancer Prevention & Control Research,
Jonsson Comprehensive Cancer Center

Understanding Epigenetic Regulation during Hematopoiesis and in Leukemia: Lessons from MLL Family Histone Methyltransferases (Jan. 24, 2019)
Patricia Ernst, PhD
Professor of Pediatrics and Pharmacology; Pre-Clinical Associate Director, Medical Scientist Training Program
University of Colorado, Denver, Anschutz Medical Campus

Epigenetics of Cancer: Causes and novel treatment (Jan. 10, 2019)
Shelley Berger, PhD
Daniel S. Och University Professor; Director, Epigenetics Institute
University of Pennsylvania

View of the Cancer Epigenome – Implications for Cancer Prevention, Interception and Therapy (Nov. 8, 2019)
Stephen B. Baylin, MD
Virginia and D.K. Ludwig Professor for Cancer Research; Professor of Oncology and Medicine,
Johns Hopkins Medicine

Using Pancreatic Organoids To Model, Detect, And Treat Cancer (Oct. 11, 2018)
Senthil Muthuswamy, PhD
Chief, Division of Translational Research and Technology Innovation; Deputy Director, Translational Research; Director, Cell Biology Program
The Cancer Center at Beth Israel Deaconess Medical Center, Harvard Medical School

Patient Reported Outcomes: An Odyssey From Efficacy to Effectiveness to Implementation (Sept. 27, 2018)
Deborah Schrag, MD, MPH
Chief, Population Sciences; Attending Physician, Gastrointestinal Cancer Center; Professor of Medicine
Harvard Medical School

The Promise and Potential of Immunotherapy in Breast Cancer (Sept. 20, 2018) - Video not available
Elizabeth Mittendorf, MD PhD
Robert and Karen Hale Distinguished Chair in Surgical Oncology. Director Breast Immuno-Oncology Program
Dana-Farber/Brigham and Women's Cancer Center

Fall 2017 - Spring 2018

Translating Chimerica Antigen Receptors into Solid Tumors (May 1, 2018)
Avery D. Posey, Jr., PhD
University of Pennsylvania, Philadelphia, Pennsylvania

Colorectal Cancer Risk: Insights into the Underlying Mechanisms and Biology (Apr. 12, 2018)
Graham Casey, PhD
Professor, Center for Public Health Genomics, Department of Public Health Sciences
University of Virginia School of Medicine

The Pathways Study: a Multi-Level Prospective Cohort Study of Breast Cancer Survivorship, Prognosis and Outcomes (Mar. 22, 2018)
Lawrence Kushi, ScD
Director of Scientific Policy, Division of Research
Kaiser Permanente, Oakland, CA

Codon bias: The silent secret of RAS oncogenes (Mar. 15, 2018)
Christopher Counter, PhD
Professor of Pharmacology and Cancer Biology
Duke University School of Medicine

More than pretty pictures: Development of multiplexed tissue assays to support breast cancer clinical trials (Feb. 22, 2018)
Jennifer Giltnane, MD, PhD 
Physician-Scientist, Anatomic Pathology & Laboratory Medicine

Resistance to Immunotherapy – Lessons Learned from Genitourinary Cancers (Feb. 8, 2018)
Charles Drake, MD, PhD
Directory, Genitourinary Oncology; Co-Director, Immunotherapy Program; Associate Director, Clinical Research
Herbert Irving Comprehensive Cancer Center
New York-Presbyterian/Columbia University Medical Center

Tackling pancreatic cancer from many directions (Jan. 30, 2018)
Lynn Matrisian, PhD, MBA
Chief Science Officer
Pancreatic Cancer Action Network, Washington, D.C.

Maintaining our genomes: whenever, wherever (Jan. 25, 2018)
Agnel Sfeir, PhD
Associate Professor, Department of Cell Biology
Skirball Institute, NYU Langone

Bridging the Chasm between Genomic Discovery & Translation: Communication, Behavior & Care Delivery (Jan. 11, 2018)
Anita Y. Kinney, PhD, RN, FAAN
Professor, Division of Epidemiology, Dept of Internal Medicine, Associate Director for Population Sciences
University of New Mexico Health Sciences Center

Accelerating CART Cells from the Model T to Driverless (Nov. 16, 2017)
Avery D. Posey, Jr., PhD.
Department of Pathology and Laboratory Medicine

University of Pennsylvania

Preclinical Targeting of Breast Cancer Metastasis: Through the TGF-β Lens (Nov. 9, 2017)
Lalage Wakefield, DPhil
Senior Investigator
Lab of Cancer Biology and Genetics
National Cancer Institute

Opportunities and Challenges for Pancreatic Cancer Clinical Trials (Oct. 27, 2017)
M. Shaalan Beg, MD.
MD Dedman Family Scholar in Clinical Care Medical Director
Clinical Research Office Co-Leader
GI Oncology Harold Simmons Cancer Center
UT Southwestern Medical Center 

Thymidylate Synthase as a Chemotherapeutic Target in the Treatment of Colorectal Cancer (Oct. 19, 2017)
Edward Chu, MD
Professor of Medicine and Pharmacology & Chemical Biology
Stanley M. Marks-OHA Chair in Hematology-Oncology Research
Division of Hematology-Oncology Deputy Director
UPMC Hillman Cancer Center University of Pittsburgh School of Medicine

Fall 2016 - Spring 2017

Identification of Targetable Proteins and Processes Downstream of Steroid Receptors in Breast Cancer (May 11, 2017)
Donald P. McDonnell, PhD
Glaxo-Wellcome Professor of MCB and Chairman; Department of Pharmacology and Cancer Biology; Professor of Medicine
Duke University School of Medicine

A New Home for the Epigenetic Machinery: SET-ing Methyl Marks on Microtubules (Apr. 13, 2017)
Cheryl Walker, PhD
Center for Precision Environmental Health
Baylor College of Medicine, Houston, TX

Drug Development in the Era of Genomics and Immunotherapy (Apr. 7, 2017)
Alex Adjei, M.D., PhD
Professor of Oncology
Mayo Clinic, Rochester, MN

Augmenting and broadening T-cell responses against mutated tumour new-antigens (Apr. 6, 2017) - Video not available
Bruce WSRobinson, AM, CitWA, MBBS, MD, FRACP, FRCP, DTM& H, FCCP
Professor of Medicine, School of Medicine and Pharmacology, Director, TheFathering Project, UWA
School of Medicine and Pharmacology, Harry PerkinsInstitute
Sir Charles Gairdner Hospital, Nedlans, Perth, Australia

Predictors of response to immune checkpoint therapy in solid tumors (Mar. 30, 2017)
Gyan Bhanot, PhD
Professor of Department of Molecular Biology and Biochemistry
Rutgers University

SWI/SNF (BAF) Chromatin Remodeling Complexes are Frequently Mutated in Cancer: Mechanisms and Vulnerabilities (Mar. 9, 2017)
Charles M. Roberts, MD
Cancer Center Director and EVP
St. Jude Children’s Research Hospital

Population and Tumor Heterogeneity in Cancer Genome Scienceand Precision Oncology (Feb. 23, 2017)
John D. Carpten, PhD
Professor, Department of Urology; Chair, Department of Translational Genomics; Director, USC Institute of Translational Genomics
USC Keck School of Medicine

For better or for worse: Immune modulation of pancreatic cancer (Dec. 15, 2016)
Steven D. Leach, MD
David M. Rubenstein Chair and Director, Rubenstein Center for Pancreatic Cancer Research
Memorial Sloan Kettering Cancer Center, New York, NY

Lymphoplegia in cancer treatment: The role of HMGB1 and mitochondria in tumor infiltrating lymphocytes (Oct.3, 2016)
Michael T. Lotze, MD
Professor of Surgery, Immunology, and Bioengineering; Assistant Vice Chancellor
University of Pittsburgh Schools of the Health Sciences

Triumphs and Challenges in Treating Metastatic Melanoma (Sept. 29, 2016) - Video not available
Harriet Kluger, MD
Professor of Medicine and Medical Oncology

Psychosocial Oncology Care: Variations on a Complex Theme (Sept. 15, 2016)
Donald Rosenstein, MD
Professor, Department of Psychiatry and Medicine; Director, Comprehensive Cancer Support Program
University of North Carolina, Chapel Hill, SC

Fall 2015 - Spring 2016

Risk Models and Cancer Prevention (May 12, 2016)
Mitch Gail, MD, PhD
Senior Investigator, National Cancer Institute Division of Cancer Epidemiology and Genetics, Biostatistics Branch

Molecular Control of Metastatic Progression (April 28, 2016)
Sohail Tavazoie, MD, PhD
Associate Professor; Head, Laboratory of Systems Cancer Biology
The Rockefeller University

Viewing the Immune System Through the Lens of Gene Regulatory Networks (April 21, 2016)
Harinder Singh, PhD
Professor of Pediatrics; Director, Division of Immunology; Director, Center for Systems Immunology
Cincinnati Children's Hospital

Biomarker Accessible and Chemically AddressableSubtypes of Neoplastic Disease (April 14, 2016)
Michael White, PhD
Professor and Grant A. Dove Distinguished Chair for Research in Oncology
UT Southwestern Medical Center, Dallas, TX

Recruitment, Retention, Surgical and Medication Adherence Studies with African Americans: Lessons Learned (March 31, 2016)
Marvella E. Ford, PhD
Professor, Department of Public Health Sciences
Associate Director, Cancer Disparities
Hollings Cancer Center,Medical University of South Carolina, Charleston

Hypoxia, Metabolism, and Tumor Progression (March 29, 2016)
M. Celeste Simon, PhD
Scientific Director and Investigator, Abramson Cancer Research Institute
Professor, Cell and Developmental Biology
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

MicroDNAs, Histone Chaperones and MCM Homologs: New Windows into Genomic Instability (March 10, 2016)
Anindya Dutta, MD, PhD
Harry F. Byrd Professor and Chair, Department of Biochemistry & Molecular Genetics
Professor of Pathology
University of Virginia, Charlottesville, VA

Addressing Social Determinants of Cancer Health Disparities Using a Community-Based Participatory Approach (February 25, 2016)
Chanita Hughes-Halbert, PhD
Associate Dean for Assessment and Evaluation, College of Medicine
Professor, Department of Psychiatry and Behavioral Sciences
Endowed Chair for Cancer Equity
Hollings Cancer Center, Medical University of South Carolina

(February 18, 2016) - Video not available
Timothy N. J. Bullock, PhD
Associate Professor of Pathology
University of Virginia School of Medicine

Implementing Lung Cancer Screening: Why Does It Have To Be So Hard? (January 28, 2016)
Michael K. Gould, MD, MS
Director for Health Services Research and Implementation Science
Kaiser Permanente Southern California

Use of Dual-Mode Cellular Imaging in Cancer Vaccine Development (January 21, 2016)
Jeff W.M. Bulte, MS, PhD
Russell H. Morgan Dept. of Radiology and Radiological Science
Cellular Imaging Section and Vascular Biology Program
Institute for Cell Engineering
The Johns Hopkins University School of Medicine

FoxO regulation and function in aging and development (January 14, 2016)
Patrick J. Hu, MD, PhD
Associate Professor, Departments of Internal Medicine and Cell & Developmental Biology
University of Michigan

Treating Melanoma with the Immune System (May 7, 2015)
Antoni Ribas, MD, PhD
Director,Tumor Immunology Program
Jonsson Comprehensive Cancer Center
University of California, Los Angeles

Conferences & Special Events

"Cancer Immunotherapy: Advances and Challenges"
(May 17-18, 2017)
Third National Veterans Health Affairs Research Conference

Request Access

Research affiliates without a VUnet ID can request access by submitting a ticket through our Support Portal. Please provide:

  • Name
  • Email address
  • Phone
  • Affiliation
  • Summary: Enter “Request VUnetID"